Facebook
Twitter
LinkedIn
Forward41st Annual Pittsburgh Schizophrenia Conference
Introduction
The Pittsburgh Schizophrenia Conference is typically an annual in person meeting at which the advances in schizophrenia research and treatment are reviewed by experts in the field. This year’s meeting will be in person at the Sheraton Station Square.
Gerard E. Hogarty Excellence in Schizophrenia Research Memorial Award
Professor Gerard Hogarty was a faculty member of the Department of Psychiatry and a member of the UPMC Western Psychiatric Hospital for more than 30 years. Until his passing in 2006, Professor Hogarty pursued important questions related to the nature and treatment of schizophrenia – namely relapse prevention and inter-episodic social function. His career in clinical research led to major advancements in the treatment of individuals with schizophrenia and his work continues to be recognized both nationally and internationally. In addition to his research endeavors, Professor Hogarty was an incredibly talented teacher and mentor who played a significant role in the career development of many respected researchers and clinicians in the field.
UPMC/WPH/WBH participants, if your department is paying for your tuition, the Departmental Journal Transfer form can be found here Please have your supervisor complete it BEFORE YOU REGISTER.
Target Audience
Who Should Attend:
The conference is designed to disseminate the latest clinical and research findings to a wide audience: psychiatrists and other mental health clinicians, including nurses, social workers, psychologists, service coordinators, researchers, patients and their relatives, mental health policy administrators and others who intend to keep current regarding treatment and research in schizophrenia.
Learning Objectives
Educational Objectives
At the completion of this program, participants should be able to:
- Review the potential clinical benefits of muscarinic acetylcholine receptor agonists for treating the core symptoms of schizophrenia. The history as well as the molecular, cellular and neurocircuit mechanisms of action of this novel class of antipsychotic medicine will also be reviewed.
- Effectively integrate, weigh, and critique the various relationships between cannabinoid exposure and psychosis outcomes and apply the knowledge about the risks of psychosis with exposure to cannabinoids in their clinical practice.
- Increase their understanding of the implications improving behavioral health outcomes through enhanced and focused medical management.
- Review and gain knowledge on the potential benefits of treating cognitive impairments in persons with schizophrenia.
- Compare preceding mental health-related diagnoses, prescription drug use, and behavioral health services utilization in adolescent and young adult patients diagnosed with a first episode of Schizophrenia vs. those with Major Depressive Disorder.
7:30 am Registration and Continental Breakfast
8:30 to 8:40 am Introduction and Background
K.N. Roy Chengappa, MD
8:40 to 8:45 am Introduction of Dr. Steven M. Paul by Dr. Anantha Shekhar
8:45 to 9:45 am Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia.
Steven M. Paul, MD
9:45 to 10:00 am Break – visit the Art Show - Purchases must be made via credit card payment only
10:00 to 11:00 am Gone to pot – the complex relationships between Cannabis, Cannabinoids and Psychosis.
Deepak (Cyril) D’Souza, MD
11:00 to 12:00 pm Head and Shoulders and Beyond: Advances in Clinical Behavioral/Physical Health Integration
John G. Lovelace
12:00 to 12:15 Lorraine Williams scholarships announced
Jessica Gannon, MD
12:15 to 1:15 Lunch – On your own
1:15 to 2:30 pm Presentation of Hogarty Award
Review of Work – Shaun Eack, PhD
Presentation of Plaque– Susan Hogarty, RN, MSN
Gerard E. Hogarty Excellence in Schizophrenia Research Memorial Lecture: Navigating the Social Landscape in Schizophrenia: Understanding and Improving Social Cognition and Motivation.
Michael F. Green, PhD
2:30 to 3:30 pm A Retrospective Exploratory Analysis of Medical and Pharmacy Claims Data Preceding the First Episode of Schizophrenia vs. Major Depressive Disorder in Adolescents and Young Adults
Kangho Suh, PharmD, PhD & Tushita Mayanil, MBBS, MD
3:30 to 3:45 pm Break – visit the Art Show – Purchases must be made via credit card payment only
3:45 pm Closing Remarks
K.N. Roy Chengappa, MD
4:00 pm Adjournment
All presentations are introductory to intermediate instructional levels.
Course Director
K.N. Roy Chengappa, MD
Professor of Psychiatry
University of Pittsburgh School of Medicine
Chief, Comprehensive Recovery Services
UPMC Western Psychiatric Hospital
Pittsburgh, PA
2024 Gerard E. Hogarty Excellence in Schizophrenia Research Memorial Award Winner
Michael F. Green, PhD
Distinguished Professor
UCLA David Geffen School of Medicine
Department of Psychiatry
West Los Angeles VA Healthcare Center
Los Angeles, CA
Faculty
Shaun M. Eack, Ph.D.
James and Noel Browne Endowed Chair
Professor, School of Social Work
Professor, Department of Psychiatry
University of Pittsburgh
Vikram Sodhi ’94 Professor of Psychiatry
Chair, Research and Development Committee
Director Schizophrenia Neuropharmacology Research Group at Yale (SNRGY)
Director, Neurobiological Studies Unit, VACHS
Director VA-CMHC Schizophrenia Research Clinic
Director, Yale Center for the Science of Cannabis and Cannabinoids
John G. Lovelace
Senior Advisor
UPMC Insurance Services Division
US Steel Tower
Pittsburgh, PA
Tushita Mayanil, MBBS, MD
Assistant Professor of Psychiatry
University of Pittsburgh
Pittsburgh, PA
Anantha Shekhar, MD, PhD
Senior Vice Chancellor for the Health Sciences
John and Gertrude Petersen Dean, School of Medicine
University of Pittsburgh
Kangho Suh, PharmD, PhD
Assistant Professor
University of Pittsburgh, School of Pharmacy
Pittsburgh, PA
Steven M. Paul, MD
Professor of Psychiatry and Neurology
Washington University School of Medicine
St. Louis, MO
Jessica M. Gannon, MD
Medical Director of WPH Ambulatory eRecord
Medical Director of the CRS Ambulatory Clinics
CRS Director of Education and Training
Associate Professor, University of Pittsburgh School of Medicine
Attending Psychiatrist, Western Psychiatric Hospital UPMC
Pittsburgh, PA
Susan Hogarty, RN, MSN
Psychiatric Clinical Nurse Specialist
Research Program Administrator
ASCEND Program
UPMC Western Psychiatric Hospital
Pittsburgh, PA
Continuing Education Credit
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Psychologists
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer psychology continuing education by the American Psychological Association. University of Pittsburgh maintains responsibility for this course. Psychologists completing this course receive 5.25 continuing education credits.
Licensed/Clinical Social Workers, Licensed Professional Counselors, Licensed Marriage and Family Therapists: LSW/LCSW/LPC/LMFT
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Pittsburgh maintains responsibility for this course. Social workers completing this course receive 5.0 continuing education credits.
Counselors
Education and Consultative Services of UPMC Western Psychiatric Hospital has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5059. Programs that do not qualify for NBCC credit are clearly identified. Education and Consultative Services of UPMC Western Psychiatric Hospital is solely responsible for all aspects of the programs. This conference is approved for 5.25 hours.
Other Healthcare Professionals
Peer Specialists and other health care professionals are awarded maximum of .525 Continuing Education Units (CEU's) for this day of the conference. One CEU is equal to 10 contact hours.
- Please retain your certificates in a safe place. Replacements cost $30 for those that come from our office (Gen. CEU; NCC).
- Except for physicians requesting CME continuing education credit, variable credits are not provided. Participants requesting must attend the entire day.
- Although the evaluation is not mandatory, we appreciate your participation. Please expect the certificates from our office in four to six weeks post-conference. Those obtained from the registration site can be accessed immediately.
Available Credit
- 5.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 5.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 5.25 APA
- 5.00 ASWB
- 5.25 Attendance